The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Washout: how long is long enough, and for what purpose

This is a generated summary. It shows the 9 most-liked posts from a topic of 71, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
BN
bench_notesTL4 Moderator1 Feb 2025#2
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Picking up the opening post: that is the part I would want checked first.

Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the injectable dose. Comparing them by mass is meaningless.

23 likes 18mo
RE
r.erdoganTL2 Moderator19 Feb 2025#5
batchlog, post #1: Washout: how long is long enough, and for what purpose — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me that reports a purity figure, names a technique, gives a wavelength, and stops. No gradient, no column, no injection… Go to post

Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady state and how long it takes to clear after stopping.

32 likes in reply to #1 17mo
ZO
z.onwukaTL2 Moderator31 Mar 2025#14
i.amankwah, post #10: Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that, concentration is rising with each dose. The clinical implication: escalating before 4 weeks means escalating before steady state. Go to post

Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein. That is relevant to understanding how much free drug is available.

28 likes in reply to #10 16mo
AS
a.silvaTL2 Moderator3 May 2025#23
lc_gradient, post #6: Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to individual biology (gut motility, kidney and liver function). It explains why two people on the same dose have different response magnitudes. Go to post

On post #19 — agreed on the reasoning, with one qualification.

Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments might be needed.

33 likes in reply to #6 15mo
HK
h.karlsenTL2 Moderator21 May 2025#28
a.batista, post #4: Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up. Go to post

Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.

24 likes in reply to #4 14mo
I
IMainwaringTL3Regular3 Jun 2025#32
bench_notes, post #2: Picking up the opening post: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the injectable dose. Comparing them by mass is meaningless. Go to post

Worth separating two things that post #28 runs together.

Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein. That is relevant to understanding how much free drug is available.

25 likes in reply to #2 14mo
MI
m.ibarraTL2 Moderator26 Jun 2025#39
o.cousineau, post #24: Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance. Go to post

Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.

24 likes in reply to #24 13mo
C
chromatogramTL4Analytical chemist11 Jul 2025 · edited#44

This follows post #41 rather than contradicting it.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

26 likes 13mo
NL
n.laurentTL2 Moderator2 Sep 2025 · edited#62

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

31 likes 11mo

Read the full topic (71 posts)

This topic was closed 45 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

TopicParticipantsRepliesViewsActivity
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
BAWADAKLS+11 15 43k 2mo
About the Pharmacokinetics category
Half-life, accumulation, steady state, albumin binding, and why weekly dosing works. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
KTVSMNARF 4 32k 8mo
Peak-to-trough ratio at steady state for a weekly agent — the long version
Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means…
CTRSWAVUC+57 61 708 1d
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
EDRFCHLIAK+110 126 14k 4mo
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
AWBWCEAWS+128 139 3k 3mo

Related topics — sharing the tags semaglutide, missed dose, worked example

TopicParticipantsRepliesViewsActivity
A 10 mg vial reconstituted three different ways, compared — the long version
A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the…
JMBTEDAKSG+146 158 47k 9mo
Follow-up: How to disagree with an answer you were given, well
How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title. Context below, and I have tried to include…
RMCCHO 2 16k 30d
Reading U-100 graduations, with a conversion table — one year on
Reading U-100 graduations, with a conversion table — one year on Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have…
AICDSBGHNN+3 7 662 4mo
Subcutaneous absorption kinetics and site differences
Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. I would like to understand what this number means before I repeat…
NRVRMRNSS+15 19 3.9k 12mo
The mass-error checker and its intended scope
The mass-error checker and its intended scope Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
VBLWCTKPA+149 167 42k 2y